Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0A2VZ
|
|||
| Former ID |
DIB013152
|
|||
| Drug Name |
D-3252
|
|||
| Synonyms |
SARS vaccine, Protein Sciences Corp; SARS-S deltaTM
Click to Show/Hide
|
|||
| Indication | Coronavirus infection [ICD-11: 1D92; ICD-10: B34.2] | Phase 1 | [1] | |
| Company |
Protein Sciences Corp
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C10H14O5
|
|||
| Canonical SMILES |
CC1C(C(C=CO1)OC(=O)C)OC(=O)C
|
|||
| InChI |
1S/C10H14O5/c1-6-10(15-8(3)12)9(4-5-13-6)14-7(2)11/h4-6,9-10H,1-3H3/t6?,9-,10+/m0/s1
|
|||
| InChIKey |
NDEGMKQAZZBNBB-YNMRDIRWSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Protein Sciences Corporation. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.